Content about Hanspeter Spek

February 8, 2013

During a quarterly conference call Thursday, Sanofi president global operations Hanspeter Spek noted that Sanofi's consumer arm Chattem will be relaunching the heartburn remedy Rolaids.

PARIS — During a quarterly conference call Thursday, Sanofi president of global operations Hanspeter Spek noted that Sanofi's consumer arm Chattem will be relaunching the heartburn remedy Rolaids.

"We plan to relaunch the product, which has been absent of the American markets for production problems on the side of J&J," he told analysts. "We intend to launch the product by the end of 2013, which will further accelerate the performance of Chattem in the United States."

April 25, 2011

Customers are seeing purple again — reminiscent of another switch that took advantage of the eye-catching color purple. Sanofi-Aventis through its Chattem division in March launched Allegra, the last of the second-generation antihistamines. And purple-powered displays, like this in a Walmart in Lancaster, Pa., dotted the retail pharmacy landscape.


April 12, 2011

A U.S. Department of Agriculture study published in March in the journal Proceedings of the National Academy of Sciences has found that ragweed season is almost 16 days longer than it was in 1995 due to changes in the first frost line of the fall in North America. The first frost steadily has been creeping northward and later into the year, lead researcher Lewis Ziska wrote. That’s 16 more days of allergy relief sales — especially good news for Chattem as it shepherds its recently switched Allegra antihistamine through its first year.

BELTSVILLE, Md. — A U.S. Department of Agriculture study published in March in the journal Proceedings of the National Academy of Sciences has found that ragweed season is almost 16 days longer than it was in 1995 due to changes in the first frost line of the fall in North America. The first frost steadily has been creeping northward and later into the year, lead researcher Lewis Ziska wrote.

January 25, 2011

Sanofi-Aventis and its U.S. consumer healthcare division Chattem on Tuesday afternoon announced the Food and Drug Administration has approved the Allegra (fexofenadine HCl) family of allergy medication products for over-the-counter use in adults and children 2 years of age and older.

PARIS — Sanofi-Aventis and its U.S. consumer healthcare division Chattem on Tuesday afternoon announced the Food and Drug Administration has approved the Allegra (fexofenadine HCl) family of allergy medication products for over-the-counter use in adults and children 2 years of age and older.

Products will be on store shelves in March, the companies announced.